Congenital Ataxia with Progressive Cerebellar Atrophy, Camptodactyly, and Hypertrichosis: A Novel Recognizable Phenotype for NALCN Heterozygous Variants
Neuropediatrics · 01.06.2025 · 56 (03) · 185-193
DOI: 10.1055/a-2524-9091 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neuropediatrics, erschienen am 01.06.2025. Verfasst von Jacopo Sartorelli und 10 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Muscular and Neurodegenerative Diseases, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Cerebellar Ataxia. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Non-selective sodium leak channel (NALCN) protein encoded by the NALCN gene is of key importance for neuronal cell excitability. Previous reports showed that biallelic NALCN pathogenic variants cause infantile hypotonia with psychomotor retardation and characteristic facies 1 (IHPRF1) while monoallelic variants lead to congenital contractures of the limbs and face, hypotonia, and developmental delay (CLIFAHDD). In our work, we aimed to expand the heterozygous NALCN-related clinical spectrum, presenting two affected individuals and a literature review.
Methods
We describe two new unrelated subjects harboring monoallelic NALCN pathogenic variants identified through clinical exome sequencing and review the current literature of other heterozygous NALCN patients.
Results
The c.3542G > A (p.Arg1181Gln) and the novel c.3423C > A (p.Phe1141Leu) heterozygous missense variants were disclosed in two subjects manifesting a similar phenotype characterized by congenital ataxia with progressive cerebellar atrophy, camptodactyly, and hypertrichosis of the arms (CAPCACH). Other NALCN subjects with overlapping features have already been reported. A combination of these clinical and neuroimaging findings suggests the definition of the new CAPCACH phenotype.
Conclusion
We expand the heterozygous NALCN-related clinical spectrum from the more severe CLIFFAHDD to the milder CAPCACH phenotype. These conditions should be considered in the differential diagnosis of syndromic congenital ataxias, and the presence of camptodactyly and/or hypertrichosis may represent peculiar diagnostic clues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Unit of Muscular and Neurodegenerative Diseases, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Neurology, Epilepsy and Movement Disorders Unit, Bambino Gesù Children's Hospital, IRCCS, Full Member of European Reference Network on Rare and Complex Epilepsies, EpiCARE, Rome, Italy.
- Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy.
- Rare Diseases and Medical Genetics Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
ORCID-Profile: Jacopo Sartorelli, Francesco Nicita
Zitieren
APA
Sartorelli, J., Travaglini, L., Garone, G., Dentici, M. L., Sinibaldi, L., Digilio, M. C., Novelli, A., Agolini, E., D'Amico, A., Bertini, E., & Nicita, F. (2025). Congenital Ataxia with Progressive Cerebellar Atrophy, Camptodactyly, and Hypertrichosis: A Novel Recognizable Phenotype for NALCN Heterozygous Variants. Neuropediatrics, 56(03), 185-193. https://doi.org/10.1055/a-2524-9091
Vancouver
Sartorelli J, Travaglini L, Garone G, Dentici ML, Sinibaldi L, Digilio MC, et al. Congenital Ataxia with Progressive Cerebellar Atrophy, Camptodactyly, and Hypertrichosis: A Novel Recognizable Phenotype for NALCN Heterozygous Variants. Neuropediatrics. 2025;56(03):185-193. doi:10.1055/a-2524-9091
BibTeX
@article{Sartorelli2025,
author = {Sartorelli, Jacopo and Travaglini, Lorena and Garone, Giacomo and Dentici, Maria L and Sinibaldi, Lorenzo and Digilio, Maria C and Novelli, Antonio and Agolini, Emanuele and D'Amico, Adele and Bertini, Enrico and Nicita, Francesco},
title = {Congenital Ataxia with Progressive Cerebellar Atrophy, Camptodactyly, and Hypertrichosis: A Novel Recognizable Phenotype for NALCN Heterozygous Variants},
journal = {Neuropediatrics},
year = {2025},
volume = {56},
number = {03},
pages = {185--193},
doi = {10.1055/a-2524-9091}
}
EUVIMED